Siemens opens Cologne research centre

Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.

Siemens has also been researching innovative biochips for breast cancer tests. ‘Biochips can perform hundreds and, in extreme cases, hundreds of thousands of diagnostic tests simultaneously. Many different tumour characteristics must be investigated in order to identify the possibility of various therapies,’ the firm points out. ‘Biochips are therefore especially suitable for performing a high number of required tests both fast and efficiently.’
The Siemens ‘Breast Care Solutions’ package combines various imaging techniques including ultrasound, mammography and magnetic resonance imaging, and these are now supplemented by laboratory diagnostic tests and DP based evaluation systems.

28.10.2008

Read all latest stories

Related articles

Photo

Siemens Healthineers and Flywheel

Partnership for healthcare research collaboration

Medical data management company Flywheel announced a partnership and enterprise license agreement with Siemens Healthineers. Under the agreement, Flywheel will deliver a cloud-based research…

Photo

How to deliver more and better care at lower costs

Moving the needle in MRI productivity

In an industry where every second and every click counts, workflow inefficiencies consume as much as a third of the MRI procedure time. This is a key area of focus where technology advances can…

Photo

The most compact .55-T full body scanner

Lungs plus A&E MRI scans – no problem

Low, light and with a field strength: 0.55-tesla with added new digital technologies. Indeed, this is a very new class of MRI scanner created by Siemens Healthineers. We interviewed Christiane…

Related products

Subscribe to Newsletter